BRIEF published on 05/28/2026 at 19:11, 2 months 4 days ago ABIONYX Pharma: Review of the first quarter of 2026 Revenue Treasury Funding Innovative Therapies Sepsis
BRIEF published on 05/28/2026 at 19:11, 2 months 4 days ago ABIONYX Pharma Reports Stable First Quarter and Robust Financing for Future Growth Clinical Trials Capital Increase Financial Stability ABIONYX Pharma Revenue 2026
PRESS RELEASE published on 05/28/2026 at 19:06, 2 months 4 days ago Inside Information / Other news releases ABIONYX Pharma updates its operations and cash position for Q1 2026. Consolidated revenue of €0.8M, cash reserves of €2.8M. Funding secured till 2028 through capital increase and non-dilutive loan Revenue Cash Position Funding ABIONYX Pharma Q1 2026
PRESS RELEASE published on 05/27/2026 at 07:30, 2 months 6 days ago Inside Information / Other news releases ABIONYX Pharma launches a fully secured capital increase with preferential subscription rights and structured debt financing for up to EUR 33M. Finnja Capital commits EUR 10M in a non-dilutive loan Capital Increase Preferential Subscription Rights ABIONYX Pharma Fenja Capital Structured Debt Financing
BRIEF published on 04/08/2026 at 23:59, 3 months 23 days ago ABIONYX Reports Share Capital and Voting Rights Details Euronext Paris Share Capital Voting Rights Financial Disclosure ABIONYX
PRESS RELEASE published on 04/08/2026 at 23:54, 3 months 23 days ago Inside Information / Other news releases ABIONYX Pharma releases monthly statement of total voting rights and shares for March 31, 2026, in accordance with French regulations Shares French Regulations Total Voting Rights Biotech Company ABIONYX Pharma
BRIEF published on 03/17/2026 at 19:31, 4 months 15 days ago ABIONYX Pharma makes available the 2025 Universal Registration Document AMF Biopharmaceutical Registration Document ABIONYX Pharma Sepsis
PRESS RELEASE published on 03/17/2026 at 19:26, 4 months 15 days ago Inside Information / Other news releases ABIONYX Pharma announces the availability of its Universal Registration Document for the year 2025, filed with the AMF and accessible on their website AMF Biopharmaceutical Universal Registration Document ABIONYX Pharma Sepsis
BRIEF published on 03/03/2026 at 19:40, 4 months 29 days ago ABIONYX: Information on voting rights and shares as of February 28, 2026 Euronext Paris Share Capital Voting Rights AMF ABIONYX
BRIEF published on 03/03/2026 at 19:40, 4 months 29 days ago ABIONYX Announces February Voting Rights Update Euronext Paris Voting Rights AMF Regulations ABIONYX Pharma February 2026
Published on 08/01/2026 at 01:20, 1 day 10 hours ago Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 1 day 10 hours ago Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 1 day 11 hours ago Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 07/31/2026 at 23:20, 1 day 12 hours ago Pentagon I Capital Corp. Announces Conditional Acceptance of Qualifying Transaction with Prospectiva Resources Ltd.
Published on 08/02/2026 at 08:15, 3 hours 20 minutes ago Holcim signs agreement to divest its business in the Philippines
Published on 08/01/2026 at 16:35, 18 hours 59 minutes ago HIZENERGY Enters Global Top Tier with BloombergNEF Tier 1 Listing
Published on 07/31/2026 at 19:55, 1 day 15 hours ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA Reaches Agreement with Financing Partners on Extension of Standstill Agreement and Continuation of Restructuring Process
Published on 07/31/2026 at 19:05, 1 day 16 hours ago Eurobattery Minerals presents the Q2 report for 2026 as the Company accelerates the development of the San Juan tungsten project
Published on 07/31/2026 at 21:00, 1 day 14 hours ago Carrefour completes the sale of its minority stake in CarrefourSA in Turkey to Yeni Mağazacılık A.Ş., operator of the A101 retail chain and controlled by the Aydın Group
Published on 07/31/2026 at 19:13, 1 day 16 hours ago Covivio - Information on Treasury shares transactions between July 29th, 2026 and July 31st, 2026
Published on 07/31/2026 at 18:30, 1 day 17 hours ago Covivio Hotels - 2026 Half-year financial report
